ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
64,298.20
0.63%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. PhaseBio Pharmaceuticals Inc (PHAS)

  7. PhaseBio Pharmaceuticals Inc (PHAS) Noticias

PHAS

PhaseBio Pharmaceuticals (PHAS)

PhaseBio Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PHAS
FechaHoraFuenteTítuloSímboloCompañía
30/05/202315:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
19/05/202315:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/05/202315:23Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
03/04/202315:06Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
14/02/202316:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
21/12/202205:10Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
04/11/202215:44Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/10/202207:00Business WirePhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy CodeNASDAQ:PHASPhaseBio Pharmaceuticals Inc
28/09/202211:05TipRanksPhasebio Pharmaceuticals (PHAS) was downgraded to a Hold Rating at NeedhamNASDAQ:PHASPhaseBio Pharmaceuticals Inc
15/08/202205:15TipRanksH.C. Wainwright Keeps Their Buy Rating on Phasebio Pharmaceuticals (PHAS)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
12/08/202215:15TipRanksPhasebio Pharmaceuticals (PHAS) Receives a Buy from NeedhamNASDAQ:PHASPhaseBio Pharmaceuticals Inc
12/08/202207:30Business WirePhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business HighlightsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/06/202207:18TipRanks10 Penny Stocks that Could Deliver Exponential ReturnsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
17/05/202205:26TipRanksH.C. Wainwright Thinks Phasebio Pharmaceuticals’ Stock is Going to RecoverNASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/05/202210:55TipRanksAnalysts Offer Insights on Healthcare Companies: Phasebio Pharmaceuticals (PHAS) and Hookipa Pharma (HOOK)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/05/202205:51Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/05/202205:00Business WirePhaseBio Announces Successful Pre-BLA Meeting with U.S. FDA for BentracimabNASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/05/202205:00Business WirePhaseBio Pharmaceuticals Reports First Quarter 2022 Financial Results and Recent Business HighlightsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
22/04/202215:15Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
18/04/202204:35TipRanksAnalysts Offer Insights on Healthcare Companies: Phasebio Pharmaceuticals (PHAS) and InMode (INMD)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
07/04/202215:00Business WirePhaseBio Pharmaceuticals to Participate in the 21st Annual Needham Healthcare ConferenceNASDAQ:PHASPhaseBio Pharmaceuticals Inc
04/04/202207:00Business WirePhaseBio Announces Positive Results from Phase 2b Trial for BentracimabNASDAQ:PHASPhaseBio Pharmaceuticals Inc
25/03/202214:15TipRanksNeedham Thinks Phasebio Pharmaceuticals’ Stock is Going to RecoverNASDAQ:PHASPhaseBio Pharmaceuticals Inc
25/03/202205:25TipRanksH.C. Wainwright Reiterates Their Buy Rating on Phasebio Pharmaceuticals (PHAS)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/03/202215:16Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/03/202215:00Business WirePhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business HighlightsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
08/03/202207:00Business WirePhaseBio Pharmaceuticals Announces Bentracimab Manufacturing UpdateNASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/02/202215:00Business WirePhaseBio Pharmaceuticals to Participate in the Cowen 42nd Annual Health Care ConferenceNASDAQ:PHASPhaseBio Pharmaceuticals Inc
10/02/202207:00Business WirePhaseBio Announces Bentracimab Phase 2b Trial Data Accepted for Late Breaking Clinical Research Presentation at the 2022 American College of Cardiology (ACC.22) Annual Scientific SessionNASDAQ:PHASPhaseBio Pharmaceuticals Inc
04/02/202208:31Edgar (US Regulatory)Schedule 13gNASDAQ:PHASPhaseBio Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PHAS

Su Consulta Reciente

NYSE
JPM
JP Morgan Chase
COIN
ETHUSD
Ethereum
AMEX
XLV
Health Care Select Sector
AMEX
XLF
Financial Select Sector
FX
EURUSD
Euro vs US Dollar
USOTC
ADDYY
Adidas (QX)
USI
USTECH100
US Tech 100
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
AXP
American Express
USOTC
RHHBY
Roche (QX)
NYSE
CVX
Chevron
NYSE
KO
Coca Cola
NYSE
DIS
Walt Disney
NYSE
VZ
Verizon Communications
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados